Anti-interferon activity of adenovirus-2-encoded VAI and VAII RNAs in translation in cultured human cells

Virus Research

Volumn 42, Issue 1-2, 1996, Pages 53-63

  Mori, Ken Ichi ^a   Jüttermann, Ruth ^b,d   Wienhues, Ulla ^b,e   Kobayashia, Kayoko ^a   Yagi, Michiko ^a   Sugimoto, Toshiyuki ^c   Tjia, Sian T ^b   Doerfler, Walter ^b   Hosokawaa, Keiichi ^a,f,g  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF COLOGNE   (Germany)

^c HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Boehringer Research Centre   (Germany)

^f Institute of Bio Microbiology   (Japan)

^g Blood Center Red Cross   (Japan)

Author keywords

Adenovirus VA RNAs; CAT assays; Interferon; Translation of viral mRNA

Indexed keywords

GAMMA INTERFERON;

ADENOVIRUS 2; ARTICLE; CELL STRAIN KB; CYTOTOXICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; RNA SYNTHESIS; RNA TRANSLATION;

ADENOVIRIDAE; FELIS CATUS; HUMAN ADENOVIRUS TYPE 2;

EID: 17144453800     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1702(95)01309-1     Document Type: Article

References (38)

1. Akusjärvi, G., Svensson, C. and Nygard, O. (1987) A mechanism by which adenovirus-associated RNAI controls translation in a transient expression assay. Mol. Cell. Biol. 7, 549-551.
2. Coccia, E.M., Vaiman, D., Raber, J., Marziali, G., Fiorucci, G., Orsatti, R. et al. (1991) Protein binding to the interferon response enhancer correlates with interferon induction of 2′-,5′-oligoadenylate synthetase in normal and interferon-resistant Friend cells. J. Virol. 65, 2081-2087.
3. Denhardt, D.T. (1966) A membrane-filter technique for the detection of complementary DNA. Biochem. Biophys. Res. Commun. 23, 641-646.
4. Ghadge, G.D., Malhotra, P., Furtado, M.R., Dhar, R. and Thimmapaya, B. (1994) In vitro analysis of virus-associated RNAI (VAI RNA): Inhibition of the double-stranded RNA-activated protein kinase PKR by VAI RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain. J. Virol. 68, 4137-4151.
5. Gorman, C.M. Moffat, L.F. and Howard, B.H. (1982) Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2, 1044-1051.
6. Graham, F.L. and van der Eb, A.J. (1973) Transformation of rat cells by DNA of human adenovirus 5. Virology 54, 536-539.
7. Green, S.R., Manche, L. and Mathews, M.B. (1995) Two functionally distinct RNA-binding motifs in the regulatory domain of the protein kinase DAI. Mol. Cell. Biol. 15, 358-364.
8. Isaacs, A. and Lindemann, M. (1957) Virus interference. I. The interferon, Proc. R. Soc. Lond. B. Biol. Sci. 147, 258-267.
9. Jones, N. and Shenk, T. (1979) Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17, 683-689.
10. Jüttermann, R., Hosokawa, K. Kochanek, S. and Doerfler, W. (1991) Adenovirus type 2 VAI RNA transcription by polymerase III is blocked by sequence-specific methylation. J. Virol. 65, 1735-1742.
11. Kaufman, R.J. (1985) Identification of the components necessary for adenovirus translational control and their utilization in cDNA expression vectors. Proc. Natl. Acad. Sci. USA 82, 689-693.
12. Kaufman, R.J., Murtha, P. and Davies, M.V. (1987) Translational efficiency of polycistronic mRNAs and their utilization to express heterologous genes in mammalian cells. EMBO J. 6, 187-193.
13. Kerr, I.M. and Brown, R.E. (1978) pppA2′p5′A2′p5′A: An inhibitor of protein synthesis synthesized with an enzyme fraction from interferon treated cells. Proc. Natl. Acad. Sci. USA 75, 256-260.
14. Kitajewski, J., Schneider, R.J., Safer, B., Munemitsu, S.M., Samuel, C.E. Thimmappaya, B. and Shenk, T. (1986) Adenovirus VA1 RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase. Cell 45, 195-200.
15. Kruczek, I. and Doerfler, W. (1983) Expression of chloramphenicol acetyltransferase gene in mammalian cells under the control of adenovirus type 12 promoters: Effect of promoter methylation on gene expression. Proc. Natl. Acad. Sci. USA 80, 7586-7590.
16. Lebleu, B., Sen, G.C., Shaila, S., Cabrer, B. and Lengyel, P. (1976) Interferon, double-stranded RNA, and protein phosphorylation. Proc. Natl. Acad. Sci. USA 73, 3107-3111.
17. Lengyel, P. (1982) Biochemistry of interferons and their actions. Annu. Rev. Biochem. 51, 251-282.
18. Mathews, M.B. (1975) Genes for VA-RNA in adenovirus 2. Cell 6, 223-229.
19. McCormack, S.J., Thomis, D.C. and Samuel, C.E. (1992) Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent PI eIF-2α protein kinase. Virology 188, 47-56.
20. Müller, U. and Doerfler, W. (1987) Fixation of the unmethylated or the 5′-CCGG-3′ methylated adenovirus late E2A promoter-cat gene construct in the genome of hamster cells: gene expression and stability of methylation patterns. J. Virol. 61, 3710-3720.
21. O'Malley, R.P., Mariano, T.M., Siekierka, J. and Mathews, M.B. (1986) A mechanism for the control of protein synthesis by adenovirus VA RNA I. Cell 44, 391-400.
22. Orita, K., Ando, S. and Kurimoto, M. (1987) Synergism between human tumor necrosis factor and human interferon-α: effects on cells in culture. Acta Med. Okayama 41, 155-160.
23. Pestka, S., Langer, J.A., Zoon, K.C. and Samuel, C.E. 1987. Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
24. Pettersson, U. and Philipson, L. (1975) Location of sequences on the adenovirus genome coding for the 5.5S RNA. Cell 6, 1-4.
25. Reich, P.R., Forget, B.G., Weissman, S.M. and Rose, J.A. (1966) RNA of low molecular weight in KB cells infected with adenovirus type 2. J. Mol. Biol. 17, 428-439.
26. Reichel, P.A., Merrick, W.C., Siekierka, J. and Mathews, M.B. (1985) Regulation of a protein synthesis initiation factor by adenovirus-associated RNA. Nature (London) 313, 196-200.
27. Rigby, P.W.J., Dieckmann, M., Rhodes, C. and Berg, P. (1977) Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J. Mol. Biol. 113, 237-251.
28. Roy, S., Delling, U., Chen, C.-H., Rosen, C.A. and Sonenberg, N. (1990) A bulge structure in HIV-I TAR RNA is required for TAT binding and TAT-mediated trans-activation. Genes Dev. 4, 1365-1373.
29. Samuel, C.E. (1993) The eIF-2α protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 168, 7603-7606.
30. Schneider, R.J., Safer, B., Munemitsu, S.M. Samuel, C.E. and Shenk, T. (1985) Adenovirus VAI RNA prevents phosphorylation of the eukaryotic initiation factor 2α subunit subsequent to infection. Proc. Natl. Acad. Sci. USA 82, 4321-4325.
31. Siekierka, J., Mariano, T.M., Reichel, P.A. and Mathews, M.B. (1985) Translational control by adenovirus: lack of virus-associated RNAI during adenovirus infection results in phosphorylation of initiation factor eIF-2 and inhibition of protein synthesis. Proc. Natl. Acad. Sci. USA 82, 1959-1963.
32. Söderlund, H., Pettersson, U., Vennström, B., Philipson, L. and Mathews, M.B. (1976) A new species of virus-coded low molecular weight RNA from cells infecled with adenovirus type 2, Cell 7, 585-593.
33. Svensson, C. and Akusjärvi, G. (1985) Adenovirus VA RNA I mediates a translational stimulation which is not restricted to the viral mRNAs. EMBO J. 4, 957-964.
34. Thomis, D.C. and Samuel, C.E. (1995) Mechanism of Interferon action: Characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase. J. Virol. 69, 5195-5198.
35. Weinmann, R., Brendler, T.G., Raskas, H.J. and Roeder, R.G. (1976) Low molecular weight viral RNAs transcribed by RNA polymerase III during adenovirus 2 infection. Cell 7, 557-566.
36. Weyer, U., and Doerfler, W. (1985) Species dependence of the major late promoter in adenovirus type 12 DNA. EMBO J. 4, 3015-3019.
37. Wienhues, U., Hosokawa, K., Hoeveler, A., Siegmann, B. and Doerfler, W. (1987) A novel method for transfection and expression of reconstituted DNA-protein complexes in eukaryotic cells. DNA 6, 81-89.
38. Zock, C. and Doerfler, W. (1990) A mitigator sequence in the downstream region of the major late promoter of adenovirus type 12 DNA. EMBO J. 9, 1615-1623.